AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00874302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proellex
Description: One 25mg capsule taken orally once every day.
Study NCT00874302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proellex
Description: Two 25mg capsules Proellex (50mg) taken orally once every day
Study NCT06139991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (BDA MDI HFO)
Description: Randomized participants will receive Treatment A (BDA MDI HFO) on Day 1 under fasted condition.
Study NCT04869800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-398
Description: Test Drug
Study NCT04869800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-501, D745
Description: Reference Drug
Study NCT06002503 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venezuelan Equine Encephalitis DNA Vaccine
Description: Venezuelan Equine Encephalitis DNA Vaccine Candidate
Study NCT06002503 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PharmaJet Stratis Needle-free Injection System
Description: Intramuscular Needle-free Injection System (Jet Injector)
Study NCT06002503 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PharmaJet Tropis Needle-free Injection System
Description: Intradermal Needle-free Injection System (Jet Injector)
Study NCT06548646 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thoracic Interfascial Plane Block
Description: The Thoracic Interfascial Plane Block (TIPB) is a regional anesthesia technique used to manage postoperative pain, particularly in thoracic and breast surgeries. This block involves the injection of a local anesthetic into the fascial plane between the thoracic muscles, targeting the nerves that supply the chest wall and upper abdominal area. It includes Pecto-Intercostal Fascial Plane Block (PIFB) and Serratus Intercostal Fascial Plane Block (SIFB).
Study NCT06548646 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spinae Plane Block
Description: The Erector Spinae Plane Block (ESPB) is a regional anesthesia technique used to manage pain, particularly in thoracic and abdominal surgeries. This block involves the injection of a local anesthetic into the plane between the erector spinae muscle and the transverse processes of the vertebrae.
Study NCT06139991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B (BDA MDI HFA)
Description: Randomized participants will receive Treatment B (BDA MDI HFA) on Day 1 under fasted condition.
Study NCT06375343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRO-240
Description: -Propylene glycol 0.3%, Polyethylene glycol 400 0.5%, and Glycerin 0.2%. Ophthalmic solution.
Study NCT06375343 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Optive®
Description: - Carboxymethylcellulose 0.5%, and Glycerin 0.9%. Ophthalmic solution.
Study NCT04908839 — intervention group
Intervention type: OTHER
Intervention: spot-25 questionnaire
Description: spot-25 questionnaire
Study NCT05548959 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pneumatonometry after microshunt implantation
Description: Pneumatonometry was perfomed over 24 hours at 5 point in time (5 AM, 11 AM, 4 PM, 8 PM, and midnight) using a Pneumatonometer. The measurement was conducted in the habitual position.
Study NCT05548959 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pneumatonometry after ab interno trabeculectomy
Description: Pneumatonometry was perfomed over 24 hours at 5 point in time (5 AM, 11 AM, 4 PM, 8 PM, and midnight) using a Pneumatonometer. The measurement was conducted in the habitual position.
Study NCT05279430 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Inspiratory muscle training
Description: Patients allocated to the IMT arm will be instructed to train at home twice daily, for 20 minutes each session, using a Threshold inspiratory muscle trainer (Respironics Inc., Parsippany, NJ). They will be instructed by a physiotherapist responsible for training intervention and educated to maintain diaphragmatic breathing during the training period. The subjects will start breathing at a resistance equal to 25% to 30% of their maximal inspiratory mouth pressure (MIP) for 1 week. The respiratory therapist will examine the patients at weekly intervals by checking the diary card and measuring the MIP each time. The resistance will be modified each session according to the 25% to 30% of their MIP measured.
Study NCT06152588 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: 3 months (12 weeks) strict TRE intervention: Participants will be instructed to reduce their eating window by minimum 3 hours compared to habitual eating, with an eating window below 10 hours. The timing of the eating window is self-selected but should be placed between 6 am and 8 pm. Diet during the eating window is ad libitum with no further dietary restrictions.~9 months (40 weeks) individually adjusted TRE intervention: An individual plan will be made based on participants' experiences during the strict TRE. Different choices of individual adjustment and support will be provided, including 1) eating window adjustments and the possibility of 'days off', 2) provision of a list of allowed calorie and caffeine free beverages that can be consumed outside the window, 3) continued opportunity to participate in peer-support group meetings, 4) extra phone calls with a project worker to discuss challenges or strategies to continue with TRE etc., and 5) further involvement of relatives.
Study NCT05167448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ES104
Description: ES104 is administered via Intravenous infusion, at dose of 10 mg/kg, once every 14 days, every 28 days as a treatment cycle for a maximum treatment duration per patient of 2 years.
Study NCT05167448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ES104
Description: ES104 is administered via Intravenous infusion, at dose of 12.5 mg/kg, once every 14 days, every 28 days as a treatment cycle for a maximum treatment duration per patient of 2 years.
Study NCT05167448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ES104
Description: ES104 is administered via Intravenous infusion, at dose of RP2D, once every 14 days, every 28 days as a treatment cycle for a maximum treatment duration per patient of 2 years.
Study NCT04823351 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Surgical Mask
Description: The randomized wards will be wearing either FFP2 masks or surgical masks for 8 weeks. Then a cross-over will occur for another 8 weeks.
Study NCT06469060 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant anti-PD-1 with DOC chemotherapy
Description: Patients were treated with one cycle of Tislelizumab 200 mg monotherapy on day~1. At 3 weeks and with intervals of 3 weeks between each cycle (weeks 3, 6, 9 and 12), patients received a total of four combination cycles consisting of Tislelizumab 200 mg, docetaxel 50 mg m-2 and oxaliplatin 100 mg m-2 intravenously at the beginning of each cycle, plus oral capecitabine 850 mg m-2 twice daily on days 1-14 of each cycle.
Study NCT05623293 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: eye - Optcial coherence tomography
Description: pre and postoperative
Study NCT06215833 — intervention group
Intervention type: DRUG
Intervention: Propofol
Description: All children will undergo anesthesia via Propofol bolus injection in induction then Propofol infusion in maintenance of anesthesia and will be given after total recovery, Cetal suppositories as postoperative analgesia
Study NCT06215833 — intervention group
Intervention type: DRUG
Intervention: Sevoflurane
Description: All children will undergo anesthesia via Sevoflurane will be given during induction then through maintenance of anesthesia and will be given after total recovery, Cetal suppositories as post operative analgesia
Study NCT06593600 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7544
Description: Subcutaneous (SC) administration
Study NCT06593600 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: SC administration
Study NCT06656078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1. WORKING MEMORY TASK:
Description: Arithmetic task: backward counting with serial 3 subtractions out loud. Group 1 and Group 2 participants will be asked to count backwards with serial 3 subtractions out loud while walking 10 meters. There is considerable disruption of performance because of simultaneous articulatory suppression. However, when errors were observed they were calculated to be numerically close to the correct figure which suggests that performance was not completely disrupted by suppression of articulation.
Study NCT06656078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 2. VISUAL AND VERBAL FLUENCY TASK
Description: Modified Stroop test or Stroop colour word test: Participants are asked to name the colour of ink that each word is printed. It is the most frequent test used to show attention bias in anxiety patients. This test will appear on the mobile phone in their hands while they walk to increase the effect of cognitive loading.
Study NCT06656078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3. MOTOR TASK:
Description: Carrying a tray with four glasses filled with water. Participants will be asked to hold a tray of glasses filled with water and walk 10 meters to calculate the effect of cognitive loading on gait.
Study NCT05083858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classical Physiotherapy Program + Cervical Stabilization Exercises
Description: First of all, patients will be taught correct craniocervical flexion movement without activation of superficial muscles in different positions (supine, prone, crawling, sitting, standing). The program will be continued by asking to maintain the cranio-cervical flexion position during all movements. In order to gain dynamic stabilization, unilateral, bilateral, contralateral, ipsilateral and reciprocal extremity movements will be added to the program together with craniocervical flexion movement. Resistance will be added to the exercises as control of the movement is achieved. The exercises will progress from static to dynamic, from stationary floors to moving floors, from simple movements to complex movements.
Study NCT05083858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classical Physiotherapy Program + Oculomotor Exercises
Description: Oculomotor Exercises is a program consisting of exercises that support proprioception in the cervical region. It consists of 4 main contents; Sacadic Eye movements, Gaze stability, Head/eye coordination, Head repositioning exercise.
Study NCT05083858 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classical Physiotherapy Program
Description: Conventional TENS will be applied to apply analgesic current. TENS application will be made to the cervical paravertebral region, using four 5 x 5 cm adhesive surface electrodes, at 80 Hz frequency for 20 minutes, 100 msec.~All participants will be asked to lie in a prone position. The neck will be in a neutral position. The hot pack will be applied to the cervical region for 20 minutes.~Classical massage will be applied for 20 minutes using the Swedish technique. The technique will be performed on the upper and neck region of the back with 3 strokes, 3 kneading and 3 strokes. The patient will be massaged while lying in the prone position.~Stretching/Posture Exercises Exercises will be applied as a 5-10 minute warm-up-cool-down program at the beginning and end of the study. Cervical flexor, lateral flexor, rotator muscles, pectorals, inferior shoulder joint capsule will be stretched. In addition to this, posture exercises will also be done.
Study NCT05844215 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MMP-9 and TIMP-1
Description: Examine level of serum MMP-9 and TIMP-1
Study NCT06662890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supersaturated oxygen
Description: Supersaturated O2 (SSO2) therapy immediately following primary percutaneous coronary intervention (PCI) using radial artery access in the cardiac catheter laboratory.~https://www.zoll.com/products/supersaturated-oxygen-therapy
Study NCT06662890 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham (No Treatment)
Description: Control (sham) procedure involving wrist manipulation in addition to standard care.
Study NCT06438081 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Cook double-balloon catheter
Description: To compare whether Cook double-balloon catheter or Propess able to achieve vaginal delivery with a shorter priming to delivery interval
Study NCT06438081 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Cook double-balloon catheter
Description: To compare whether Cook double-balloon catheter or Propess able to achieve vaginal delivery with a shorter priming to delivery interval
Study NCT04880187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AXA1125
Description: AXA1125 administered BID with or without food
Study NCT04880187 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo administered BID with or without food
Study NCT05490797 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: app based training with conventional therapy
Description: The experimental group will receive an additional mobile application therapy including , dexterity fine motor skills, bowling game, scribble game and peglight game in addition to the conventional therapy for hand function.
Study NCT05490797 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional therapy
Description: conventional hand function rehabilitation therapy including, strengthening exercises which consist of palm down wrist flexion exercise, dexterity( shifting exercise) and fine motor skills(nine peg hole exercise)
Study NCT06661395 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Wingate Anaerobic Test with Virtual Reality
Description: Wingate Anaerobic Power Test Protocol, commonly used for assessing anaerobic capacity, involves a warm-up followed by testing. The warm-up includes 5 minutes of dynamic cycling, incorporating sprints. During the test, the athlete pedals at maximum effort for 30 seconds with added weight. Heart rate is monitored, and power output is measured every 5 seconds. Peak and average power values are calculated.~This protocol will be gamified for VR goggles. The warm-up simulates cycling in a forest. Athletes sprint for 5 seconds every minute to escape a train, with prompts on the screen. The testing phase includes a simulated race, with athletes pedaling at maximum effort for 30 seconds to compete against rivals, signaled by flares and a countdown.
Study NCT06598800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug: BG-T187
Description: Intravenous administration
Study NCT06675955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Description: Ocrelizumab will be administered according to the regimen in the parent study.
Study NCT05081258 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: passive Alveolar Molding
Description: A passive palate plate (passive Alveolar Molding) will be inserted within the first week after birth. The pAM appliance will be modified on regular appointments and remain until surgical lip closure (6-7 months of life). After surgical lip closure, infants will receive a nostril retainer and the treatment with the pAM appliance will continue until palate closure (10-12 months of life).
Study NCT05081258 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nasoalveolar Molding
Description: A passive palate plate will be inserted within the first week after birth. A nasal stent will be added to the palate plate after one week (NAM appliance). The NAM appliance will be modified on regular appointments and remain until surgical lip closure (6-7 months of life). After surgical lip closure, infants will receive a nostril retainer and will be treated with a passive palate plate without nasal stent until palate closure (10-12 months of life).
Study NCT06484647 — intervention group
Intervention type: PROCEDURE
Intervention: Percutaneous Coronary Intervention
Description: Percutaneous coronary intervention is a procedure that require coronary stenosis dilatation with dilatation catheter balloon and generally stent implantation.~The study involve coronary stenosis at bifurcation level that require complex coronary techniques such as External Minicrush or TAP technique.
Study NCT04999709 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VeNS
Description: The VeNS device utilizes a technology called galvanic vestibular stimulation (GVS) (sometimes termed vestibular nerve stimulation (VeNS)). The device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 1 hour per day.
Study NCT04999709 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: VeNS
Description: The VeNS device utilizes a technology called galvanic vestibular stimulation (GVS) (sometimes termed vestibular nerve stimulation (VeNS)). The device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 1 hour per day.
Study NCT05287438 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Next-Generation DNA Sequencing
Description: NGS is a technique of microbiological sequencing, using 16s ribosomal RNA molecular identification has been implemented to detect bacteria and fungi present in the sample
Study NCT05287438 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Standard Culture
Description: Standard of care culture and sensitivity
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin
Description: Clarithromycin tablets.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Description: Clarithromycin tablets.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Amoxicillin capsules.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: Amoxicillin capsules.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth potassium citrate
Description: Bismuth potassium citrate tablets.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth potassium citrate
Description: Bismuth potassium citrate tablets.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: Esomeprazole tablets.
Study NCT04753437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: Vonoprazan tablets.
Study NCT05127746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aricept 5mg Tablet
Description: 1 tablet once daily
Study NCT05127746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aricept 10mg Tablet
Description: 1 tablet once daily
Study NCT05127746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-5207 A
Description: 1 patch once weekly
Study NCT05127746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-5207 B
Description: 1 patch once weekly
Study NCT06246006 — intervention group
Intervention type: OTHER
Intervention: Gene sequencing
Description: Next generation sequencing of candidate genes (JAK2, cMPL, CALR, ASXL1 and NF-E2)
Study NCT05339867 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prevent Maternal Mortality using Mobile technology (PM3)
Description: PM3: The app will include:~1. integrated self-management and tailored health messaging feature~2. support center based on social support gaps which will also provide a centralized place for identifying healthcare providers and facilities~3. multimedia resource kit comprised of videos, current events, news feeds, podcasts, and support groups related to women's postpartum health and community resources~4. a feature that will update women on maternal and reproductive health policies that impact women.
Study NCT05827471 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of colon cancer
Description: Clinical diagnosis results
Study NCT05212545 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: maltodextrin taken daily for 4 weeks with water
Study NCT05212545 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic supplement
Description: Prebiotic supplement taken daily for 4 weeks with water
Study NCT05212545 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic combination
Description: prebiotic oligosaccharides mixture taken daily for 4 weeks with water
Study NCT05212545 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic oligosaccharides
Description: Prebiotic oligosaccharides taken daily for 4 weeks with water
Study NCT05317091 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laughter yoga practiced
Description: In this study, 8 sessions of laughter yoga were applied to the nurses in the experimental group as an intervention, twice a week for 4 weeks. Due to the Covid-19 pandemic; Laughter Yoga sessions were held on the web through the 'ZOOM' program.~For this reason, it is recommended that the laughter yoga sessions be done with a group and that the group should consist of at least five people in order to provide group dynamics. Sessions are planned according to the days and hours that nurses can attend. Sessions 1st group Monday-Thursday between 12:00-13:00; 2nd group Tuesday-Friday between 17:00-18:00; The third group was held on Wednesday-Saturday between 20:00-21:00. The nurses were constantly contacted (whatsapp, phone) to ensure that they attend the sessions regularly and that there is no interruption in the sessions. No experiment was performed on the control group during the study. However, after the research, a 4-week laughter yoga was given to the nurses who wanted it.